Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Yusen Zhou, Yang Yang, Jingwei Huang, et al.
Viruses (2019) Vol. 11, Iss. 1, pp. 60-60
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu, Feiran Wang, Chenguang Shen, et al.
Science (2020) Vol. 368, Iss. 6496, pp. 1274-1278
Open Access | Times Cited: 1069
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang, Christopher D. Hillyer, Lanying Du
Trends in Immunology (2020) Vol. 41, Iss. 5, pp. 355-359
Open Access | Times Cited: 913
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 722-733.e11
Open Access | Times Cited: 480
Middle East respiratory syndrome
Ziad A. Memish, Stanley Perlman, Maria D. Van Kerkhove, et al.
The Lancet (2020) Vol. 395, Iss. 10229, pp. 1063-1077
Open Access | Times Cited: 444
COVID-19: Drug Targets and Potential Treatments
Carmen Gil, Tiziana Ginex, Inés Maestro, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12359-12386
Open Access | Times Cited: 433
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang, Jian Shang, Shibo Jiang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 416
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Jianhui Nie, Qianqian Li, Jiajing Wu, et al.
Nature Protocols (2020) Vol. 15, Iss. 11, pp. 3699-3715
Open Access | Times Cited: 383
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
Fei Yu, Lanying Du, David M. Ojcius, et al.
Microbes and Infection (2020) Vol. 22, Iss. 2, pp. 74-79
Open Access | Times Cited: 359
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Gaurav Chauhan, Marc Madou, Sourav Kalra, et al.
ACS Nano (2020) Vol. 14, Iss. 7, pp. 7760-7782
Open Access | Times Cited: 347
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
Shibo Jiang, Lanying Du, Zheng‐Li Shi
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 275-277
Open Access | Times Cited: 335
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
Liqiang Feng, Qian Wang, Chao Shan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 224
Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
Muhammad Tahir ul Qamar, Saman Saleem, Usman Ali Ashfaq, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 179
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Onat Kadioglu, Mohamed E.M. Saeed, Henry Johannes Greten, et al.
Computers in Biology and Medicine (2021) Vol. 133, pp. 104359-104359
Open Access | Times Cited: 161
An overview on the seven pathogenic human coronaviruses
Mina Mobini Kesheh, Parastoo Hosseini, Saber Soltani, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Closed Access | Times Cited: 146
A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu, Feiran Wang, Chenguang Shen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 93
Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)?
Ahmet Nalbant, Tezcan Kaya, Ceyhun Varım, et al.
Revista da Associação Médica Brasileira (2020) Vol. 66, Iss. 6, pp. 746-751
Open Access | Times Cited: 75
The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach
Luisa Di Paola, Hamid Hadi‐Alijanvand, Xingyu Song, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4576-4586
Open Access | Times Cited: 74
Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 3
Open Access | Times Cited: 61
Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection
Soumya Ranjan Mahapatra, Susrita Sahoo, Budheswar Dehury, et al.
Expert Review of Vaccines (2020) Vol. 19, Iss. 9, pp. 871-885
Open Access | Times Cited: 59
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
Cuiqing Ma, Shan Su, Jiachao Wang, et al.
Microbes and Infection (2020) Vol. 22, Iss. 6-7, pp. 245-253
Open Access | Times Cited: 52
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Onat Kadioglu, Mohamed E.M. Saeed, Henry Johannes Greten, et al.
(2020)
Closed Access | Times Cited: 51
A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea
Marnie Willman, Darwyn Kobasa, Jason Kindrachuk
Viruses (2019) Vol. 11, Iss. 12, pp. 1119-1119
Open Access | Times Cited: 51
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 1, pp. 62-83
Open Access | Times Cited: 45
Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases
Xinling Wang, Shuai Xia, Qian Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3843-3843
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top